Table of Contents Chapter 1 Overview of Receptor Tyrosine Protein Kinase Targeted Drugs 1.1 Definition of Receptor Tyrosine Protein Kinase Targeted Drugs in This Report 1.2 Commercial Types of Receptor Tyrosine Protein Kinase Targeted Drugs 1.2.1 Afatinib Dimaleate 1.2.2 Dacomitinib 1.2.3 Neratinib 1.2.4 Neucardin 1.2.5 Others 1.3 Downstream Application of Receptor Tyrosine Protein Kinase Targeted Drugs 1.3.1 Oncology 1.3.2 Cardiovascular 1.3.3 Central Nervous System 1.3.4 Others 1.4 Development History of Receptor Tyrosine Protein Kinase Targeted Drugs 1.5 Market Status and Trend of Receptor Tyrosine Protein Kinase Targeted Drugs 2013-2023 1.5.1 Global Receptor Tyrosine Protein Kinase Targeted Drugs Market Status and Trend 2013-2023 1.5.2 Regional Receptor Tyrosine Protein Kinase Targeted Drugs Market Status and Trend 2013-2023 Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Receptor Tyrosine Protein Kinase Targeted Drugs 2013-2017 2.2 Sales Market of Receptor Tyrosine Protein Kinase Targeted Drugs by Regions 2.2.1 Sales Volume of Receptor Tyrosine Protein Kinase Targeted Drugs by Regions 2.2.2 Sales Value of Receptor Tyrosine Protein Kinase Targeted Drugs by Regions 2.3 Production Market of Receptor Tyrosine Protein Kinase Targeted Drugs by Regions 2.4 Global Market Forecast of Receptor Tyrosine Protein Kinase Targeted Drugs 2018-2023 2.4.1 Global Market Forecast of Receptor Tyrosine Protein Kinase Targeted Drugs 2018-2023 2.4.2 Market Forecast of Receptor Tyrosine Protein Kinase Targeted Drugs by Regions 2018-2023 Chapter 3 Global Market Status and Forecast by Types 3.1 Sales Volume of Receptor Tyrosine Protein Kinase Targeted Drugs by Types 3.2 Sales Value of Receptor Tyrosine Protein Kinase Targeted Drugs by Types 3.3 Market Forecast of Receptor Tyrosine Protein Kinase Targeted Drugs by Types Chapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Global Sales Volume of Receptor Tyrosine Protein Kinase Targeted Drugs by Downstream Industry 4.2 Global Market Forecast of Receptor Tyrosine Protein Kinase Targeted Drugs by Downstream Industry Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry 5.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Market Status by Countries 5.1.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Countries (2013-2017) 5.1.2 North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Countries (2013-2017) 5.1.3 United States Receptor Tyrosine Protein Kinase Targeted Drugs Market Status (2013-2017) 5.1.4 Canada Receptor Tyrosine Protein Kinase Targeted Drugs Market Status (2013-2017) 5.1.5 Mexico Receptor Tyrosine Protein Kinase Targeted Drugs Market Status (2013-2017) 5.2 North America Receptor Tyrosine Protein Kinase Targeted Drugs Market Status by Manufacturers 5.3 North America Receptor Tyrosine Protein Kinase Targeted Drugs Market Status by Type (2013-2017) 5.3.1 North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2013-2017) 5.3.2 North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Type (2013-2017) 5.4 North America Receptor Tyrosine Protein Kinase Targeted Drugs Market Status by Downstream Industry (2013-2017) Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry 6.1 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Market Status by Countries 6.1.1 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Countries (2013-2017) 6.1.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Countries (2013-2017) 6.1.3 Germany Receptor Tyrosine Protein Kinase Targeted Drugs Market Status (2013-2017) 6.1.4 UK Receptor Tyrosine Protein Kinase Targeted Drugs Market Status (2013-2017) 6.1.5 France Receptor Tyrosine Protein Kinase Targeted Drugs Market Status (2013-2017) 6.1.6 Italy Receptor Tyrosine Protein Kinase Targeted Drugs Market Status (2013-2017) 6.1.7 Russia Receptor Tyrosine Protein Kinase Targeted Drugs Market Status (2013-2017) 6.1.8 Spain Receptor Tyrosine Protein Kinase Targeted Drugs Market Status (2013-2017) 6.1.9 Benelux Receptor Tyrosine Protein Kinase Targeted Drugs Market Status (2013-2017) 6.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Market Status by Manufacturers 6.3 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Market Status by Type (2013-2017) 6.3.1 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2013-2017) 6.3.2 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Type (2013-2017) 6.4 Europe Receptor Tyrosine Protein Kinase Targeted Drugs Market Status by Downstream Industry (2013-2017) Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry 7.1 Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Market Status by Countries 7.1.1 Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Countries (2013-2017) 7.1.2 Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Countries (2013-2017) 7.1.3 China Receptor Tyrosine Protein Kinase Targeted Drugs Market Status (2013-2017) 7.1.4 Japan Receptor Tyrosine Protein Kinase Targeted Drugs Market Status (2013-2017) 7.1.5 India Receptor Tyrosine Protein Kinase Targeted Drugs Market Status (2013-2017) 7.1.6 Southeast Asia Receptor Tyrosine Protein Kinase Targeted Drugs Market Status (2013-2017) 7.1.7 Australia Receptor Tyrosine Protein Kinase Targeted Drugs Market Status (2013-2017) 7.2 Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Market Status by Manufacturers 7.3 Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Market Status by Type (2013-2017) 7.3.1 Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2013-2017) 7.3.2 Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Type (2013-2017) 7.4 Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Market Status by Downstream Industry (2013-2017) Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry 8.1 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Market Status by Countries 8.1.1 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Countries (2013-2017) 8.1.2 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Countries (2013-2017) 8.1.3 Brazil Receptor Tyrosine Protein Kinase Targeted Drugs Market Status (2013-2017) 8.1.4 Argentina Receptor Tyrosine Protein Kinase Targeted Drugs Market Status (2013-2017) 8.1.5 Colombia Receptor Tyrosine Protein Kinase Targeted Drugs Market Status (2013-2017) 8.2 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Market Status by Manufacturers 8.3 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Market Status by Type (2013-2017) 8.3.1 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2013-2017) 8.3.2 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Type (2013-2017) 8.4 Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Market Status by Downstream Industry (2013-2017) Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry 9.1 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Market Status by Countries 9.1.1 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Countries (2013-2017) 9.1.2 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Countries (2013-2017) 9.1.3 Middle East Receptor Tyrosine Protein Kinase Targeted Drugs Market Status (2013-2017) 9.1.4 Africa Receptor Tyrosine Protein Kinase Targeted Drugs Market Status (2013-2017) 9.2 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Market Status by Manufacturers 9.3 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Market Status by Type (2013-2017) 9.3.1 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2013-2017) 9.3.2 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Type (2013-2017) 9.4 Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Market Status by Downstream Industry (2013-2017) Chapter 10 Market Driving Factor Analysis of Receptor Tyrosine Protein Kinase Targeted Drugs 10.1 Global Economy Situation and Trend Overview 10.2 Receptor Tyrosine Protein Kinase Targeted Drugs Downstream Industry Situation and Trend Overview Chapter 11 Receptor Tyrosine Protein Kinase Targeted Drugs Market Competition Status by Major Manufacturers 11.1 Production Volume of Receptor Tyrosine Protein Kinase Targeted Drugs by Major Manufacturers 11.2 Production Value of Receptor Tyrosine Protein Kinase Targeted Drugs by Major Manufacturers 11.3 Basic Information of Receptor Tyrosine Protein Kinase Targeted Drugs by Major Manufacturers 11.3.1 Headquarters Location and Established Time of Receptor Tyrosine Protein Kinase Targeted Drugs Major Manufacturer 11.3.2 Employees and Revenue Level of Receptor Tyrosine Protein Kinase Targeted Drugs Major Manufacturer 11.4 Market Competition News and Trend 11.4.1 Merger, Consolidation or Acquisition News 11.4.2 Investment or Disinvestment News 11.4.3 New Product Development and Launch Chapter 12 Receptor Tyrosine Protein Kinase Targeted Drugs Major Manufacturers Introduction and Market Data 12.1 Aslan Pharmaceuticals Pte Ltd 12.1.1 Company profile 12.1.2 Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product 12.1.3 Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin of Aslan Pharmaceuticals Pte Ltd 12.2 Boehringer Ingelheim GmbH 12.2.1 Company profile 12.2.2 Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product 12.2.3 Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim GmbH 12.3 GamaMabs Pharma SA 12.3.1 Company profile 12.3.2 Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product 12.3.3 Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin of GamaMabs Pharma SA 12.4 Hanmi Pharmaceuticals Co Ltd 12.4.1 Company profile 12.4.2 Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product 12.4.3 Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin of Hanmi Pharmaceuticals Co Ltd 12.5 Jiangsu Kanion Pharmaceutical Co Ltd 12.5.1 Company profile 12.5.2 Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product 12.5.3 Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin of Jiangsu Kanion Pharmaceutical Co Ltd 12.6 Minerva Neurosciences Inc 12.6.1 Company profile 12.6.2 Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product 12.6.3 Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin of Minerva Neurosciences Inc 12.7 Pfizer Inc 12.7.1 Company profile 12.7.2 Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product 12.7.3 Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin of Pfizer Inc 12.8 Puma Biotechnology Inc 12.8.1 Company profile 12.8.2 Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product 12.8.3 Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin of Puma Biotechnology Inc 12.9 Shanghai Fosun Pharmaceutical (Group) Co Ltd 12.9.1 Company profile 12.9.2 Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product 12.9.3 Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin of Shanghai Fosun Pharmaceutical (Group) Co Ltd 12.10 XuanZhu Pharma Co Ltd 12.10.1 Company profile 12.10.2 Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product 12.10.3 Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin of XuanZhu Pharma Co Ltd 12.11 Zensun (Shanghai) Sci & Tech Co Ltd 12.11.1 Company profile 12.11.2 Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product 12.11.3 Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin of Zensun (Shanghai) Sci & Tech Co Ltd Chapter 13 Upstream and Downstream Market Analysis of Receptor Tyrosine Protein Kinase Targeted Drugs 13.1 Industry Chain of Receptor Tyrosine Protein Kinase Targeted Drugs 13.2 Upstream Market and Representative Companies Analysis 13.3 Downstream Market and Representative Companies Analysis Chapter 14 Cost and Gross Margin Analysis of Receptor Tyrosine Protein Kinase Targeted Drugs 14.1 Cost Structure Analysis of Receptor Tyrosine Protein Kinase Targeted Drugs 14.2 Raw Materials Cost Analysis of Receptor Tyrosine Protein Kinase Targeted Drugs 14.3 Labor Cost Analysis of Receptor Tyrosine Protein Kinase Targeted Drugs 14.4 Manufacturing Expenses Analysis of Receptor Tyrosine Protein Kinase Targeted Drugs Chapter 15 Report Conclusion Chapter 16 Research Methodology and Reference 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Reference

List of Tables Table Advantage and Disadvantage of Afatinib Dimaleate Table Advantage and Disadvantage of Dacomitinib Table Advantage and Disadvantage of Neratinib Table Advantage and Disadvantage of Neucardin Table Advantage and Disadvantage of Others Table Sales Volume of Receptor Tyrosine Protein Kinase Targeted Drugs by Regions 2013-2017 Table Sales Value of Receptor Tyrosine Protein Kinase Targeted Drugs by Regions 2013-2017 Table Production Volume of Receptor Tyrosine Protein Kinase Targeted Drugs by Regions 2013-2017 Table Global Sales Volume of Receptor Tyrosine Protein Kinase Targeted Drugs by Regions 2018-2023 Table Global Sales Value of Receptor Tyrosine Protein Kinase Targeted Drugs by Regions 2018-2023 Table Global Production Volume of Receptor Tyrosine Protein Kinase Targeted Drugs by Regions 2018-2023 Table Sales Volume of Receptor Tyrosine Protein Kinase Targeted Drugs by Types 2013-2017 Table Sales Value of Receptor Tyrosine Protein Kinase Targeted Drugs by Types 2013-2017 Table Sales Volume Forecast of Receptor Tyrosine Protein Kinase Targeted Drugs by Types 2018-2023 Table Sales Value Forecast of Receptor Tyrosine Protein Kinase Targeted Drugs by Types 2018-2023 Table Sales Volume of Receptor Tyrosine Protein Kinase Targeted Drugs by Downstream Industry 2013-2017 Table Sales Volume Forecast of Receptor Tyrosine Protein Kinase Targeted Drugs by Downstream Industry 2018-2023 Table North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Countries (2013-2017) Table North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Countries (2013-2017) Table North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Countries (2013-2017) Table North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Countries (2013-2017) Table North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2013-2017) Table North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Type (2013-2017) Table North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Type (2013-2017) Table North America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share by Type (2013-2017) Table North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Downstream Industry (2013-2017) Table North America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Downstream Industry (2013-2017) Table Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Countries (2013-2017) Table Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Countries (2013-2017) Table Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Countries (2013-2017) Table Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Countries (2013-2017) Table Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2013-2017) Table Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Type (2013-2017) Table Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Type (2013-2017) Table Europe Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share by Type (2013-2017) Table Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Downstream Industry (2013-2017) Table Europe Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Downstream Industry (2013-2017) Table Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Countries (2013-2017) Table Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Countries (2013-2017) Table Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Countries (2013-2017) Table Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Countries (2013-2017) Table Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2013-2017) Table Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Type (2013-2017) Table Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Type (2013-2017) Table Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share by Type (2013-2017) Table Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Downstream Industry (2013-2017) Table Asia Pacific Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Downstream Industry (2013-2017) Table Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Countries (2013-2017) Table Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Countries (2013-2017) Table Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Countries (2013-2017) Table Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Countries (2013-2017) Table Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2013-2017) Table Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Type (2013-2017) Table Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Type (2013-2017) Table Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share by Type (2013-2017) Table Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Downstream Industry (2013-2017) Table Latin America Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Downstream Industry (2013-2017) Table Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Regions (2013-2017) Table Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Regions (2013-2017) Table Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Regions (2013-2017) Table Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Market Share by Regions (2013-2017) Table Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Type (2013-2017) Table Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Type (2013-2017) Table Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue by Type (2013-2017) Table Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Revenue Share by Type (2013-2017) Table Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales by Downstream Industry (2013-2017) Table Middle East and Africa Receptor Tyrosine Protein Kinase Targeted Drugs Sales Share by Downstream Industry (2013-2017) Table Production Volume of Receptor Tyrosine Protein Kinase Targeted Drugs by Major Manufacturers 2013-2017 Table Production Value of Receptor Tyrosine Protein Kinase Targeted Drugs by Major Manufacturers 2013-2017 Table Headquarters Location and Established Time of Receptor Tyrosine Protein Kinase Targeted Drugs Major Manufacturer Table Employees and Revenue Level of Receptor Tyrosine Protein Kinase Targeted Drugs Major Manufacturer Table Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product One of Aslan Pharmaceuticals Pte Ltd Table Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product Two of Aslan Pharmaceuticals Pte Ltd Table Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin of Aslan Pharmaceuticals Pte Ltd 2013-2017 Table Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product One of Boehringer Ingelheim GmbH Table Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product Two of Boehringer Ingelheim GmbH Table Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin of Boehringer Ingelheim GmbH 2013-2017 Table Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product One of GamaMabs Pharma SA Table Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product Two of GamaMabs Pharma SA Table Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin of GamaMabs Pharma SA 2013-2017 Table Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product One of Hanmi Pharmaceuticals Co Ltd Table Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product Two of Hanmi Pharmaceuticals Co Ltd Table Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin of Hanmi Pharmaceuticals Co Ltd 2013-2017 Table Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product One of Jiangsu Kanion Pharmaceutical Co Ltd Table Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product Two of Jiangsu Kanion Pharmaceutical Co Ltd Table Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin of Jiangsu Kanion Pharmaceutical Co Ltd 2013-2017 Table Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product One of Minerva Neurosciences Inc Table Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product Two of Minerva Neurosciences Inc Table Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin of Minerva Neurosciences Inc 2013-2017 Table Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product One of Pfizer Inc Table Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product Two of Pfizer Inc Table Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin of Pfizer Inc 2013-2017 Table Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product One of Puma Biotechnology Inc Table Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product Two of Puma Biotechnology Inc Table Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin of Puma Biotechnology Inc 2013-2017 Table Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product One of Shanghai Fosun Pharmaceutical (Group) Co Ltd Table Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product Two of Shanghai Fosun Pharmaceutical (Group) Co Ltd Table Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin of Shanghai Fosun Pharmaceutical (Group) Co Ltd 2013-2017 Table Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product One of XuanZhu Pharma Co Ltd Table Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product Two of XuanZhu Pharma Co Ltd Table Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin of XuanZhu Pharma Co Ltd 2013-2017 Table Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product One of Zensun (Shanghai) Sci & Tech Co Ltd Table Representative Receptor Tyrosine Protein Kinase Targeted Drugs Product Two of Zensun (Shanghai) Sci & Tech Co Ltd Table Receptor Tyrosine Protein Kinase Targeted Drugs Sales, Revenue, Price and Gross Margin of Zensun (Shanghai) Sci & Tech Co Ltd 2013-2017